Reply to P. Potemski and K. Bujko
- 10 April 2021
- journal article
- letter
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 39 (11), 1306-1308
- https://doi.org/10.1200/jco.20.03687
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Noncancer Deaths in the PETACC 6 TrialJournal of Clinical Oncology, 2021
- Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCDJournal of Clinical Oncology, 2021
- Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer TrialJournal of Clinical Oncology, 2012